Before joining NovaMedica within five years Ivan Daskal was responsible for legal support and control of compliance with the legislation in the Russian branch of Allergan where within the frameworks of the cross-functional tasks he developed and played the key role in implementing a number of significant local and regulatory acts of the company which referred to commercial and marketing activities, organized work aimed at struggle against counterfeit products circulation in the Russian market. Earlier Ivan headed legal function in the Diagnostic Department of Abbott Laboratories LLC (Russia), in Energomash JSC and Dirol Cadbury LLC.
Ivan graduated from the Yaroslav-the-Wise Novgorod State University, faculty of law.
16 May 2024
NovaMedica team participates in the Russian Pharmaceutical Forum in St. Petersburg
14 May 2024
27 April 2024
Cell therapy could help curb progression of heart failure
20 May 2024
China may find various medicines from the Gamaleya Center interesting
20 May 2024
The number of conducted clinical trials in Russia is growing
17 May 2024
Russian scientists have created the world’s first drug for muscular dystrophy Mioshi
17 May 2024